Entia Ltd
16
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.3%
1 terminated/withdrawn out of 16 trials
90.0%
+3.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Liberty Analyzer WBC System: Reference Interval Study
Role: lead
Capillary Blood Accuracy
Role: lead
Entia Liberty: Home Study
Role: lead
Capillary-Venous Paired Collection
Role: lead
HOme USability Evaluation
Role: lead
Capillary-Venous Paired Data Collection
Role: lead
Entia Liberty: Usability Validation
Role: lead
Entia Liberty: Accuracy and Precision
Role: lead
Entia Liberty: Capillary Validation
Role: lead
Blood Testing at Entia
Role: lead
Project Affinity: Excess Cancer Blood Testing
Role: lead
PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.
Role: lead
Affinity: Hospital Trial
Role: lead
Project Aura: Co-design of a Home-based Monitoring Service
Role: lead
Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia
Role: lead
Project Aura: Home Trial of a Home-based Monitoring Service
Role: lead
All 16 trials loaded